Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Utility of Tc-99m-labeled levofloxacin as an infection-imaging agent in musculoskeletal infections

Ayesha Ammar, Shazia Fatima, Kahkashan Bahsir Mir, Sadaf Butt, Sadaf Batool, Muhammad Adnan Saeed, Noreen Marwat, Naseer Ahmed.




Abstract

Background: The purpose of this study is to ascertain the utility of Technetium (Tc)-99m-labeled levofloxacin in diagnosing musculoskeletal infections and also to observe its biodistribution in the human body. Patients who were referred with the clinical suspicion of having osteomyelitis underwent Tc-99m levofloxacin imaging.
Methods: Tc-99m-labeled levofloxacin scintigraphy was carried out in 30 patients with musculoskeletal infections and the results were compared with the culture and sensitivity of suspected lesions.
Results: Fifteen patients were true-positive, 2 were false-positive, 1 was false-negative, and 12 were true-negative. The sensitivity and specificity were 93.8% and 85.7%, respectively. The positive and negative predictive values were 88.2% and 92.3%, respectively. The biodistribution studies revealed that 7.74% ± 0.42% of the injected dose at 1 hour decreased to 5.45% ± 0.37% at 2 hours, and to 2.49% ± 0.55% at 4 hours. The liver showed a mean uptake value of 5.58% of injected activity at 1 hour, which decreased to 3.52% ± 0.30% and 2.00% ±± 0.5 0% at 2 and 4 hours, respectively. The activity in the bladder increased from the mean percentage uptake value of 5.45% ± 0.84% at 1 hour to 20.00% ± 3.67% at 2 hours and 39.67% ± 4.23% at 4 hours. The results of Student's t-test showed significant differences in the uptake values of infected and noninfected sites. Chi-square results confirmed strong association between osteomyelitis and Tc 99m Levofloxacin uptake.
Conclusion: Tc-99m-labeled levofloxacin has the potential of simulating an infection-imaging agent.

Key words: 99mTc levofloxacin, musculoskeletal infections, nuclear medicine






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.